EUVIMEDObjevte EUVIMED
Systematische ÜbersichtNetzwerk-Metaanalyse

Clinical Efficacy of Curcumin, Resveratrol, Silymarin, and Berberine on Cardio‐Metabolic Risk Factors Among Patients With Type 2 Diabetes Mellitus: A Systemic Review and Bayesian Network Meta‐Analysis

Klinische Wirksamkeit von Curcumin, Resveratrol, Silymarin und Berberin auf kardio-metabolische Risikofaktoren bei Patient:innen mit Typ-2-Diabetes mellitus: systematische Übersicht und Bayes'sche Netzwerk-Metaanalyse

Runyu Miao iD, Boxun Zhang, Danni Zhou, Mengjiao Kang, Jiaxing Tian, Linhua Zhao, Xiaolin Tong

Phytotherapy Research · 2025-12 · 39 (12) · 5617-5633

DOI: 10.1002/ptr.8431 ↗

Auf einen Blick

17 Studien mit 1.337 Teilnehmenden untersuchten Curcumin, Resveratrol, Silymarin und Berberin bei T2DM. Resveratrol war insgesamt am wirksamsten, gefolgt von Silymarin.

Fragestellung

Wie wirksam sind Curcumin, Resveratrol, Silymarin und Berberine bei kardio-metabolischen Risikofaktoren von Patient:innen mit T2DM?

Methode

Systematische Literaturübersicht; Suche in PubMed, Embase und Cochrane Library bis 31. März 2024; Bayes'sche Netzwerk- und paarweise Metaanalysen.

Ergebnisse

17 Studien mit 1.337 Teilnehmenden. Resveratrol verbesserte HOMA-IR, TC, TG, HDL, LDL, SBP und DBP vs. Placebo. Silymarin verbesserte FPG, HOMA-IR und HbA1c. HbA1c: Silymarin besser als Resveratrol (MD -2,08, 95 %-KI -3,50 bis -0,72); BMI: Curcumin besser als Resveratrol (MD -1,27, 95 %-KI -2,43 bis -0,03).

Einschränkungen

Weitere Validierung in größeren klinischen Studien mit größeren Stichproben erforderlich.

Schlussfolgerung der Autor:innen

Curcumin, Resveratrol, Silymarin und Berberine können kardio-metabolische Risikofaktoren bei T2DM verbessern; die Substanzen haben unterschiedliche klinische Vorteile.

Kernaussagen

  • Resveratrol war insgesamt am wirksamsten, gefolgt von Silymarin.
  • Silymarin verbesserte FPG, HOMA-IR und HbA1c.
  • Curcumin war bei BMI besser als Resveratrol.

Deutsche Zusammenfassung: KI-gestützt aus dem Original-Abstract erstellt; alle Zahlen wurden automatisch mit dem Original abgeglichen. Maßgeblich ist der Original-Abstract.

At a glance

Systematische Übersicht in Phytotherapy Research, published online on 2025-05-29. Written by Runyu Miao and 6 co-authors. Institution: National Center for Integrated Traditional and Western Medicine, China-Japan Friendship Hospital, Beijing, China. Major MEDLINE topics: Diabetes Mellitus, Type 2, Curcumin, Resveratrol, Berberine. Cited 10 times so far (Crossref); 59 references.

Auf einen BlickAbstraktSubjectsBibliografické údajeCiteRelated studies

Abstract (original language)

The comprehensive management of cardiovascular risk factors, including blood glucose, blood lipids, and blood pressure in type 2 diabetes mellitus (T2DM), is essential to prevent cardiovascular complications. Consequently, there is an urgent need to explore improved clinical treatment strategies by comparing the efficacy of various interventions. To assess the efficacy of herbal phytochemicals in regulating cardio‐metabolic risk factors among patients with T2DM. A systematic literature review of the English language literature from inception to March 31, 2024, was conducted using PubMed, Embase, and Cochrane Library databases. The included literature focused on treating patients with T2DM using herbal phytochemicals. ADDIS and Revman were used to conduct Bayesian network and pairwise meta‐analyses, respectively, and the surface under the cumulative ranking curve was used to obtain the ranking order of different herbal phytochemicals. This study included 17 studies involving 1,337 participants. Resveratrol was generally the most effective, followed by silymarin. Compared with the placebo, resveratrol significantly improved HOMA‐IR, total cholesterol (TC), triglycerides (TG), high‐density lipoprotein (HDL), low‐density lipoprotein (LDL), systolic blood pressure (SBP), and diastolic blood pressure (DBP) (P < 0.05); silymarin significantly improved fasting plasma glucose (FPG), HOMA‐IR, and hemoglobin A1c (HbA1c) (P < 0.05). For HbA1c, silymarin was more effective than resveratrol (MD ‐2.08, 95%Cl ‐3.50 to ‐0.72) (P < 0.05). For body mass index (BMI), curcumin was more effective than resveratrol (MD ‐1.27, 95%Cl ‐2.43 to ‐0.03) (P < 0.05). Curcumin, resveratrol, silymarin, and berberine can effectively improve cardio‐metabolic risk factors in T2DM, and different herbal phytochemicals have different clinical advantages. The therapeutic potential of resveratrol is significant in the regulation of blood glucose, blood lipids, and body weight, silymarin exhibited the best effect in reducing blood glucose, berberine could lower blood glucose and regulate blood lipids, and curcumin had a definite therapeutic effect on weight loss. However, further validation of these findings is necessary through extensive clinical studies with larger sample sizes.

Subjects

MeSH terms (MEDLINE)

Diabetes Mellitus, Type 2CurcuminResveratrolBerberineSilymarinHumansBayes TheoremBlood PressureBlood GlucoseCardiometabolic Risk FactorsCardiovascular DiseasesRisk Factors

Author keywords

Bayesian network meta‐analysisberberinecurcuminherbal medicineherbal phytochemicalsnetwork meta‐analysisphytochemicalsresveratrolsilymarintype 2 diabetes mellitus

Substances

CurcuminResveratrolBerberineSilymarinBlood Glucose

Authors and institutions

  • National Center for Integrated Traditional and Western Medicine, China-Japan Friendship Hospital, Beijing, China.
  • Institute of Metabolic Diseases, Guang' Anmen Hospital, China Academy of Chinese Medical Sciences, Beijing, China.
  • Department of Endocrinology, Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, China.
  • Department of Internal Medicine, Huangjiahu HospitaI, Hubei University of Chinese Medicine, Wuhan, China.
  • Zhejiang Chinese Medical University, Zhejiang, Hangzhou, China.

ORCID profiles: Runyu Miao

Cite

APA

Miao, R., Zhang, B., Zhou, D., Kang, M., Tian, J., Zhao, L., & Tong, X. (2025). Clinical Efficacy of Curcumin, Resveratrol, Silymarin, and Berberine on Cardio‐Metabolic Risk Factors Among Patients With Type 2 Diabetes Mellitus: A Systemic Review and Bayesian Network Meta‐Analysis. Phytotherapy Research, 39(12), 5617-5633. https://doi.org/10.1002/ptr.8431

Vancouver

Miao R, Zhang B, Zhou D, Kang M, Tian J, Zhao L, et al. Clinical Efficacy of Curcumin, Resveratrol, Silymarin, and Berberine on Cardio‐Metabolic Risk Factors Among Patients With Type 2 Diabetes Mellitus: A Systemic Review and Bayesian Network Meta‐Analysis. Phytotherapy Research. 2025;39(12):5617-5633. doi:10.1002/ptr.8431

BibTeX
@article{Miao2025,
  author = {Miao, Runyu and Zhang, Boxun and Zhou, Danni and Kang, Mengjiao and Tian, Jiaxing and Zhao, Linhua and Tong, Xiaolin},
  title = {Clinical Efficacy of Curcumin, Resveratrol, Silymarin, and Berberine on Cardio‐Metabolic Risk Factors Among Patients With Type 2 Diabetes Mellitus: A Systemic Review and Bayesian Network Meta‐Analysis},
  journal = {Phytotherapy Research},
  year = {2025},
  volume = {39},
  number = {12},
  pages = {5617--5633},
  doi = {10.1002/ptr.8431}
}
Start for free →